Summary: A new study presented at the Sleep Europe Congress in Seville, Spain, reveals that a vibrotactile sleep patch, which does not involve medication, can significantly enhance sleep quality and duration while reducing symptoms of insomnia. The research, part of the HARMONI trial, indicates that patients using the patch saw notable improvements in sleep and overall well-being, with many finding it preferable to traditional oral medications.
Key Findings:
Better Sleep: Participants using the vibrotactile sleep patch experienced significant improvements in sleep quality and duration. They also fell asleep faster.
Reduced Medication Use: After 14 days, many patients in the study reported using fewer oral medications.
Improved Quality of Life: Patients noted reduced daytime fatigue and enhancements in mood, concentration, and daily functioning.
Presentation Details: The Super Patch Company will unveil its latest research on the vibrotactile technology (VTT)-embedded sleep patch at the Sleep Europe Congress from September 24-27 in Seville, Spain. This study, part of the HARMONI trial, will present data on how the patch affects sleep quality, duration, and medication use.
Technology Overview: Vibrotactile technology involves patterns that touch the skin and send signals to the brain. This process may lead to wellness benefits.
Comments from the Company: Jay Dhaliwal, founder and CEO of Super Patch, said, “We have researched haptic technology for over a decade for various conditions and wellness applications. We are excited to share our latest sleep patch data with clinicians worldwide. We believe our VTT patches could be a valuable addition to current non-pharmacological sleep treatments with minimal side effects.”
Study Results: Participants using the VTT-embedded sleep patch showed:
Decreased time to fall asleep.
Increased sleep duration.
Improved sleep quality.
Lower global Pittsburgh Sleep Quality Index Scores.
After 14 days, most patients reported reduced reliance on oral medications and found the patch more convenient and effective compared to other sleep aids. Additionally, quality of life improved, with better daytime energy, mood, and cognitive function.
Conclusion: Researchers believe the results support adding the VTT-embedded sleep patch to current non-pharmacological sleep therapies.
Note: The product’s claims have not been reviewed by the Food and Drug Administration (FDA), and its effectiveness has not been confirmed through FDA-approved studies. The patch is not intended to diagnose, treat, cure, or prevent any disease.
